Andrii Buvailo, PhD
@abuv.bsky.social
Science & Tech Comms | AI & Digital | Life Sciences | Chemistry |
Guess what they are...?
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape
www.biopharmatrend.com
October 20, 2025 at 11:34 AM
Guess what they are...?
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
When two foundational technologies collide... they may pave the way into the future of biotech
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
AI and CRISPR—converging revolutions in biomedicine?
www.biopharmatrend.com
October 13, 2025 at 8:49 PM
When two foundational technologies collide... they may pave the way into the future of biotech
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
Сlinical trials designed without integration of relevant and informative biomarkers are 12 times more likely to fail...
www.biopharmatrend.com/artificial-i...
www.biopharmatrend.com/artificial-i...
How Lantern Pharma's AI-driven Approach Enables Precision Oncology
Explore how Lantern Pharma revolutionizes the field of precision oncology using its AI-driven RADR® platform. Uncover how the company leads the way in AI drug discovery and successfully tackles the co...
www.biopharmatrend.com
October 9, 2025 at 11:58 AM
Сlinical trials designed without integration of relevant and informative biomarkers are 12 times more likely to fail...
www.biopharmatrend.com/artificial-i...
www.biopharmatrend.com/artificial-i...
Surprising to see SPACs again, after I thought this financial vehicle got out of fashion... but here we go.
www.biopharmatrend.com/news/singapo...
www.biopharmatrend.com/news/singapo...
Singapore’s Nanyang Biologics Plans to Go Public on Nasdaq in US $1.5 Billion SPAC Deal
www.biopharmatrend.com
October 2, 2025 at 3:59 PM
Surprising to see SPACs again, after I thought this financial vehicle got out of fashion... but here we go.
www.biopharmatrend.com/news/singapo...
www.biopharmatrend.com/news/singapo...
Reposted by Andrii Buvailo, PhD
An article in BioPharmaTrend highlighted our recent earnings report, including “progress on internal assets REC-1245 (RBM39 degrader) and REC-617 (CDK7 inhibitor), alongside a $7 million milestone payment from Sanofi for a partnered immunology program.” www.biopharmatrend.com/news/recursi...
August 19, 2025 at 2:31 PM
An article in BioPharmaTrend highlighted our recent earnings report, including “progress on internal assets REC-1245 (RBM39 degrader) and REC-617 (CDK7 inhibitor), alongside a $7 million milestone payment from Sanofi for a partnered immunology program.” www.biopharmatrend.com/news/recursi...
AI in biotech is all about shifting from mainstream reductionism to holism...
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
17 Companies Pioneering AI Foundation Models in Pharma and Biotech
www.biopharmatrend.com
October 2, 2025 at 10:43 AM
AI in biotech is all about shifting from mainstream reductionism to holism...
www.biopharmatrend.com/business-int...
www.biopharmatrend.com/business-int...
Gene therapies sometimes fail, but when they work they are beautiful.
www.biopharmatrend.com/news/uniqure...
www.biopharmatrend.com/news/uniqure...
uniQure Reports Trial Success for Experimental Huntington’s Disease Gene Therapy
www.biopharmatrend.com
September 25, 2025 at 7:10 PM
Gene therapies sometimes fail, but when they work they are beautiful.
www.biopharmatrend.com/news/uniqure...
www.biopharmatrend.com/news/uniqure...
They say, #Canada has some serious edge when it comes to AI innovation... I also see in drug discovery, no?
www.biopharmatrend.com/news/merck-e...
www.biopharmatrend.com/news/merck-e...
Merck Expands Variational AI Collaboration To Up-To-$349M Deal On Two Small-Molecule Targets
www.biopharmatrend.com
September 23, 2025 at 3:59 PM
They say, #Canada has some serious edge when it comes to AI innovation... I also see in drug discovery, no?
www.biopharmatrend.com/news/merck-e...
www.biopharmatrend.com/news/merck-e...
Salt AI Raises $10M for Drag-and-Drop Platform to Build AI Workflows in Life Sciences
www.biopharmatrend.com
September 22, 2025 at 3:32 PM
Integra Therapeutics Raises €10.7 Million to Advance Gene Writing Platform and CAR-T Validation
www.biopharmatrend.com
September 19, 2025 at 9:57 PM
Gen AI for designing phages -- viruses that can infect and kill bacteria. A huge opportunity in fighting antibiotic resistance...
www.biopharmatrend.com/news/stanfor...
www.biopharmatrend.com/news/stanfor...
Stanford–Arc Team Reports AI-Made Viruses That Kill Bacteria
www.biopharmatrend.com
September 17, 2025 at 10:25 PM
Gen AI for designing phages -- viruses that can infect and kill bacteria. A huge opportunity in fighting antibiotic resistance...
www.biopharmatrend.com/news/stanfor...
www.biopharmatrend.com/news/stanfor...
Causaly Introduces Agentic Research AI Platform For Life Sciences R&D
www.biopharmatrend.com
September 16, 2025 at 10:30 PM
Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data
www.techlifesci.com/p/weekly-tec...
www.techlifesci.com/p/weekly-tec...
Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data
Is the first anti-aging drug class on the horizon? Also: David Baker’s new venture; grounding AI in chemistry & current state of medchem platforms
www.techlifesci.com
September 10, 2025 at 11:21 AM
Weekly Tech+Bio Highlights #53: Eli Lilly Opens Access to AI Models Trained on $1 Billion Worth of R&D Data
www.techlifesci.com/p/weekly-tec...
www.techlifesci.com/p/weekly-tec...
Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming
www.techlifesci.com/p/weekly-tec...
www.techlifesci.com/p/weekly-tec...
Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming
Tempus-Paige Digital Pathology Acquisition Deal, Reasoning AIs for Biology & Antibiotics
www.techlifesci.com
August 27, 2025 at 9:20 AM
Weekly Tech+Bio Highlights #52: Open AI's Accelerated Cell Reprogramming
www.techlifesci.com/p/weekly-tec...
www.techlifesci.com/p/weekly-tec...
Reposted by Andrii Buvailo, PhD
If you like to have a quick intro into digital pathology business landscape and context. this one is a good starting point 👇
open.substack.com/pub/andriibu...
open.substack.com/pub/andriibu...
Digital Pathology: Slides, AI, & Challenges
Pathology has progressed from glass slides to AI-driven digital diagnostics, promising to transform disease detection, while facing adoption and market challenges
open.substack.com
August 15, 2025 at 1:48 PM
If you like to have a quick intro into digital pathology business landscape and context. this one is a good starting point 👇
open.substack.com/pub/andriibu...
open.substack.com/pub/andriibu...
I think medical facilities are drowning in paperwork... so AI can (theoretically) be a game changer there. But we all know issues with gen AI... can it all work out well?
www.biopharmatrend.com/post/1321-am...
www.biopharmatrend.com/post/1321-am...
OpenAI-Backed Ambience Raises $243M in Series C, Reaching $1B+ Valuation
www.biopharmatrend.com
August 5, 2025 at 12:24 PM
I think medical facilities are drowning in paperwork... so AI can (theoretically) be a game changer there. But we all know issues with gen AI... can it all work out well?
www.biopharmatrend.com/post/1321-am...
www.biopharmatrend.com/post/1321-am...
Yes, controlling an iPad with your thoughts is not sci-fi any longer... and it is not Neuralink
www.biopharmatrend.com/post/1325-sy...
www.biopharmatrend.com/post/1325-sy...
Synchron Becomes First to Achieve Native Thought-Control of Apple iPad Using Brain-Computer Interface
www.biopharmatrend.com
August 4, 2025 at 6:48 PM
Yes, controlling an iPad with your thoughts is not sci-fi any longer... and it is not Neuralink
www.biopharmatrend.com/post/1325-sy...
www.biopharmatrend.com/post/1325-sy...
Yes, controlling an iPad with your thoughts is not sci-fi any longer...
www.biopharmatrend.com/post/1325-sy...
www.biopharmatrend.com/post/1325-sy...
Synchron Becomes First to Achieve Native Thought-Control of Apple iPad Using Brain-Computer Interface
www.biopharmatrend.com
August 4, 2025 at 6:47 PM
Yes, controlling an iPad with your thoughts is not sci-fi any longer...
www.biopharmatrend.com/post/1325-sy...
www.biopharmatrend.com/post/1325-sy...
Go on hate me, but I think despite all toxicity and Elon, X is still a more interesting place to hang out and learn ideas in tech... I like it here, but tech life is still happening there. So I decided to do both for now...
August 3, 2025 at 1:56 PM
Go on hate me, but I think despite all toxicity and Elon, X is still a more interesting place to hang out and learn ideas in tech... I like it here, but tech life is still happening there. So I decided to do both for now...
Fun fact about brain-computer interfaces market... Blackrock Neurotech implanted at least 29 patients with BCI, and Neuralink around 9.
But you probably never heard of Blackrock...
But you probably never heard of Blackrock...
August 2, 2025 at 3:19 PM
Fun fact about brain-computer interfaces market... Blackrock Neurotech implanted at least 29 patients with BCI, and Neuralink around 9.
But you probably never heard of Blackrock...
But you probably never heard of Blackrock...
H1 2025 Recap: Key Signals from the Tech+Bio Frontier
www.techlifesci.com/p/h1-2025-re...
www.techlifesci.com/p/h1-2025-re...
H1 2025 Recap: Key Signals from the Tech+Bio Frontier
A high-signal summary of some of the most important moves and trends shaping biotech and tech-enabled life sciences in the first half of 2025
www.techlifesci.com
July 31, 2025 at 9:07 PM
H1 2025 Recap: Key Signals from the Tech+Bio Frontier
www.techlifesci.com/p/h1-2025-re...
www.techlifesci.com/p/h1-2025-re...